Tao Jianming, Segal Brahm H, Eppolito Cheryl, Li Qingsheng, Dennis Carly G, Youn Richard, Shrikant Protul A
Department of Immunology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
J Leukoc Biol. 2006 Sep;80(3):529-37. doi: 10.1189/jlb.0106026. Epub 2006 Jun 22.
Invasive aspergillosis is a major cause of morbidity and mortality in the severely immunocompromised. The paucity of information about the mechanisms by which Aspergillus-derived factors regulate antigen-specific T cell responses in vivo poses a significant hurdle for devising effective immunization strategies to treat or prevent aspergillosis. By monitoring adoptively transferred T cell receptor transgenic, naive CD4+ (OT-II) and CD8+ (OT-I) T cells specific for distinct peptides of a nominal antigen, chicken ovalbumin (OVA), we demonstrate that sensitization with Aspergillus fumigatus (Af) extract plus OVA protein considerably enhances OT-I and OT-II T cell activation, which results in clonal expansion, primarily as a result of increased proliferation. The sensitization provided by Af extract promotes OT-I expansion accompanied by differentiation into interferon-gamma-producing cytotoxic cells. It is surprising that no effector differentiation of the induced OT-II response was observed. Moreover, the Af extract-induced OT-I and OT-II T cell expansion was transient, as considerable contraction in the numbers of detectable OT-I and OT-II T cells was evidenced by Day 10. In agreement with these observations, sensitization with Af extract plus OVA marginally promoted host immunity against an OVA-expressing thymoma (E.G7) challenge, and the protection was enhanced by resensitization with Af extract and OVA. Our results demonstrate the ability of Af extract to differentially regulate antigen-specific CD4+ and CD8+ T cell responses, resulting in limited augmentation of host immunity. This information suggests that strategies to target CD4+ T cell effector maturation may promote host immunity to Aspergillus and unexpectedly demonstrates the use for Af extract as a CD8+ T cell adjuvant.
侵袭性曲霉病是严重免疫功能低下患者发病和死亡的主要原因。关于曲霉衍生因子在体内调节抗原特异性T细胞反应机制的信息匮乏,这为设计治疗或预防曲霉病的有效免疫策略带来了重大障碍。通过监测过继转移的针对名义抗原鸡卵清蛋白(OVA)不同肽段的T细胞受体转基因幼稚CD4⁺(OT-II)和CD8⁺(OT-I)T细胞,我们证明用烟曲霉(Af)提取物加OVA蛋白进行致敏可显著增强OT-I和OT-II T细胞的活化,这导致克隆扩增,主要是增殖增加的结果。Af提取物提供的致敏促进OT-I扩增并伴随分化为产生干扰素-γ的细胞毒性细胞。令人惊讶的是,未观察到诱导的OT-II反应的效应器分化。此外,Af提取物诱导的OT-I和OT-II T细胞扩增是短暂的,因为在第10天时可检测到的OT-I和OT-II T细胞数量有相当大的收缩。与这些观察结果一致,用Af提取物加OVA致敏略微促进了宿主对表达OVA的胸腺瘤(E.G7)攻击的免疫力,并且通过用Af提取物和OVA再次致敏增强了保护作用。我们的结果证明了Af提取物差异调节抗原特异性CD4⁺和CD8⁺ T细胞反应的能力,导致宿主免疫力有限增强。这一信息表明,靶向CD4⁺ T细胞效应器成熟的策略可能促进宿主对曲霉的免疫力,并且意外地证明了Af提取物可作为CD8⁺ T细胞佐剂。